Skip to main content

Heiner Dreismann

Heiner Dreismann has joined Stemina Biomarker Discovery's board of directors. Dreismann is former president and CEO of Roche Molecular Systems and global head of business development for Roche Diagnostics. Stemina said that his experience will aid the company as its neurological disorders division, NeuroPointDx, prepares a metabolomics-based autism diagnostic test panel for market.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.